Cortexyme (CRTX) Appoints Philip Low to Its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Cortexyme (CRTX) Appoints Philip Low to Its Board

Cortexyme Appoints Dr. Philip Low to Its Board of Directors

May 20, 2022 8:01 AM EDT

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the appointment of Dr. Philip S. Low, a renowned targeted drug discovery researcher and veteran biotech entrepreneur, to the companys Board of Directors.

In conjunction with todays acquisition of Novosteo, we are very pleased to welcome a distinguished researcher, innovator, and entrepreneur of Dr. Philip Lows caliber to our Board of Directors, said David Lamond, chairman of Cortexymes Board of... More